Skip to content

Endermotherapy With Burn Hypertrophic Scars

Randomized, Controlled, Within-patient, Singleblind Study to Evaluate the Efficacy of 12-weeks of Endermotherapy With Adult Burn Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03697447
Enrollment
19
Registered
2018-10-05
Start date
2017-02-13
Completion date
2020-02-05
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Scar

Brief summary

Mechanical massage or endermotherapyTM is applied to scar tissue with the intended therapeutic value being the promotion of structural or physiological changes. These proposed changes are meant to induce more pliability, so that skin possesses the strength and elasticity required for normal mobility. The advantage of mechanical massage compared to manual massage is that it provides a standard dosage using rollers and suction valves to mobilize the tissue. However, research documenting and supporting this effect is lacking. The objective of this proposal is to document the effect of 12 weeks of endermotherapy treatment on hypertrophic scar characteristics, including erythema, pigmentation, pliability, and thickness in adult burn survivors and their subjective evaluation of itch, pain and overall scar outcome through a prospective, randomized, controlled, within-patient, single-blinded study.

Detailed description

Patients will receive 12 weeks of endermotherapy , 3 times a week.

Interventions

Endermotherapy massage (mechanic massage) of burn scar

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* females and males, of any race, 14 years or older, * a thermal injury, * at least 3 months post-burn so that the scars will be durable enough to tolerate the proposed forces, * at least 2 scar sites \>2.034 mm thick and within 0.5 mm of each other, and * signed the informed patient consent form

Exclusion criteria

* subjects who have keloids, * with a diagnosis of psychiatric illness clearly documented in their medical file, * mechanism of injury is an electrical, chemical, or cold injury, * a dermatological conditions in the region of the evaluation site, that may interfere with the study results, * a suspected or known allergy to ultrasound gel, * unable to understand French or English, or * subjects who refuse to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Skin Thickness Changesbaseline, 12, 24 and 36 weeksUltrasound skin measures, mm

Secondary

MeasureTime frameDescription
Cutometer Skin Elasticity Changesbaseline, 12, 24 and 36 weeksskin elasticity measures (r0- cutometer), mm
Mexameter Skin Erythema Changesbaseline, 12, 24 and 36 weeksErythema index measure by Mexameter, scale values of 0 to 999. The erythema values are individual for each person and depend strongly on the ethnic group. The measurements are generally used to determine changes before and after a treatment.
Itch Visual Analog Subjective Changesbaseline, 12, 24 and 36 weeksItch, Visual analog scale (score 0-none to 10-worse)
Pain Visual Analog Subjective Changes: VASbaseline, 12, 24 and 36 weeksPain, Visual analog scale (score 0-none to 10-worse)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026